| Profil de TheresaHealth and Wellness News...BlogListesRéseau | Aide |
|
29 mai Foreign Companies Going Hog Wild!Yet another non-American company is raking in American money with its H1N1 vaccine. Let's see--there have been 10 deaths in the US... definitely sounds like time to fork over hundreds of millions of dollars to Australian and European companies and to fund their vaccine research!
Australia CSL: gets $180 mln U.S. flu vaccine orderThu May 28, 2009 7:31pm EDT
MELBOURNE, May 29 (Reuters) - The United States has placed an order for $180 million worth of H1N1 flu vaccine from Australian pharmaceutical company CSL Ltd (CSL.AX), CSL said on Friday, as the number of U.S. deaths from the virus reached 12. CSL expects its swine flu H1N1 vaccine to be ready within a few months, with the company planning to start clinical trials to make sure the vaccine is safe and effective for human use. Companies are starting preliminary work on a vaccine for the flu and should begin clinical trials in the coming months, but the new vaccine would not be ready for widespread use until October, U.S. health officials said on Thursday. See [ID:nN28367585]. Australia ordered 10 million doses of the CSL vaccine on Thursday as the number of confirmed swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu">H1N1 cases in Australia topped 100. CSL's U.S. subsidiary CSL Biotherapies Inc. signed a contract with the U.S. Department of Health and Human Services to provide Novel A (swine flu story" href="http://www.reuters.com/news/globalcoverage/swineflu">H1N1) influenza vaccine antigen in bulk form, CSL said in a statement. The new vaccine will be tested in clinical trials funded by HHS. CSL shares last traded at A$29.03. (Reporting by Miranda Maxwell) 27 mai Animal Trials of Swine Flu Shot BeginI'm totally sure this is safe! Hahahahahahahahahaha....
Tuesday, May 26, 2009, 9:43am PDT
Vaxart moves possible swine flu vaccine into animal testingSan Francisco Business Times
Vaxart Inc. has started animal testing for a possible swine flu vaccine. The South San Francisco company is one of several biotech companies speeding to develop a vaccine for the H1N1 influenza. Since that strain was first reported in Mexico in early April, there have been 6,764 confirmed or probable cases in the United States, including 10 deaths. Vaxart could produce its first batch of human H1N1 vaccine by August, the company said, but human testing may not begin until the fall or later. Experts have warned that rushing to create a vaccine may cause more safety problems than tried-and-true — but slower — means of developing a vaccine. The Centers for Disease Control has isolated a strain of the H1N1 virus to ship it to vaccine makers — taking about six months before the first large amounts of vaccine are available. Others, like Vaxart, have used the genetic sequence of the virus’ key gene to construct a synthetic version that could lead to speedier production of a vaccine in the form of a capsule. Vaxart’s candidate vaccine for swine flu was developed 25 days after the company initiated the project. “Our oral vaccine could provide an important tool for swine flu pandemic preparation, because of the speed with which it could be delivered to groups such as first-line medical personnel,” Sean Tucker, Vaxart’s vice president of research, said in a prepared release. The federal government has earmarked $1 billion to the search for a swine flu vaccine, the Associated Press reported. The company, formerly called West Coast Biologicals, also is trying to develop an avian flu vaccine. Its backers have included Life Science Angels, Quantum Technology Partners, Bay Partners and Sand Hill Angels. FDA Decides Fecal Matter in Drinking Water Is BadI want to say, "No ****," but my mom reads this blog...
FDA Provides New Standards For Bottled Water
By Jared A. Favole WASHINGTON (Dow Jones)--The Food and Drug Administration is pushing more stringent testing standards for the $11 billion bottled water industry, saying companies will have to eliminate any causes of fecal contamination in water sources before they can bottle the water for sale. The FDA's new rules also require manufacturers to test source water for any forms of coliform, a group of bacteria that are mostly harmless, according to a copy of the rules scheduled to be posted in the Federal Register on Friday. If coliform is found, manufacturers must also test for fecal contamination. Water that goes into bottles is already tested for coliform and fecal contamination, but the water source itself wasn't previously required to be tested. The new rules were proposed two years ago, and bring the FDA's standards essentially in line with that of the Environmental Protection Agency, which has federal oversight of tap water. The rules go into effect Dec. 1. The FDA notes that 70% to 75% of bottled water comes from the ground, or the same places where people receive tap water. The new rule also says bottled water producers must keep records of source water testing. -By Jared A. Favole, Dow Jones Newswires; 202.862.9207; jared.favole@dowjones.com New TV Drug Ad Guidelines...because apparently, no one has been watching the store when drug dealers advertise on TV...
US warns of TV drug ads' distracting music, imagesTue May 26, 2009 6:04pm EDT
* FDA gives advice on how to present drug risks * Avoid distracting music, images, FDA says (Adds industry reaction) By Lisa Richwine WASHINGTON, May 26 (Reuters) - Television ads for drugs and medical devices should avoid distracting images and music that can reduce viewers' comprehension of potential side effects, U.S. regulators advised in guidelines proposed on Tuesday. Advertisements also should use similar type styles and voice-overs when conveying benefits and risks, the Food and Drug Administration said. The guidelines follow complaints that manufacturers use various techniques in their widely seen television ads and other promotions to downplay risks while emphasizing potential benefits. Leaving out or minimizing side-effect information is the most frequent violation the FDA cites in letters to companies complaining about misleading promotions. The draft guidelines advise manufacturers on how to present risk information adequately in print and broadcast promotions to consumers and doctors without running afoul of federal regulations. The guidelines are not mandatory. The advice covers techniques ranging from the use of contrasting colors to highlight information, the location and timing of risk details and other factors that can influence how well viewers understand a product. Prescription drug ads have drawn fire for portraying healthy-looking, active and smiling patients while explaining benefits and then rushing through or providing distractions when required risk information is conveyed. At a congressional hearing last year, a Schering-Plough Corp (SGP.N) ad for allergy drug Nasonex drew criticism for featuring a bee that flew around during a description of side effects but simply hovered while benefits were explained. In the new guidelines, the FDA said busy scenes, frequent scene changes and moving camera angles "can misleadingly minimize the risks of the product being promoted by detracting from the audience's comprehension." The FDA also warned against speeding up an announcer's description of risks. "If risk information is considerably more difficult to hear and process than benefit information because it is presented at a much faster pace, the piece will not convey an accurate impression," the agency said. Reviewers will consider "the net impression conveyed by all the elements of a piece. For this reason, manufacturers should focus not just on individual claims or presentations but on the messages conveyed by the promotional piece as a whole," the guidelines said. Groups representing drug and medical device makers said they were still reviewing the FDA guidelines. Drug companies "remain committed to producing responsible, balanced promotional materials" and have adopted voluntary guidelines that say risks "should be presented in clear, understandable language without distraction," said Ken Johnson, a spokesman for the Pharmaceutical Research and Manufacturers of America. The group represents Pfizer Inc (PFE.N), GlaxoSmithKline PLC (GSK.L) and other drugmakers. Medical device manufacturers also have adopted voluntary advertising principles that include "the need to present risk information in a manner free from distraction," said Wanda Moebius, spokeswoman for the Advanced Medical Technology Association, which represents Medtronic (MDT.N), Johnson & Johnson (JNJ.N)and other device makers. Schering-Plough spokeswoman Julie Lux said the company reviews all its promotional material "to ensure it complies with FDA regulations." The FDA guidelines were posted on the agency's website here. (Reporting by Lisa Richwine, editing by Dave Zimmerman and Matthew Lewis) FDA Finds It's No Good at Its Real Job, and Decides to Expand Its MissionLet's see: the FDA frequently approves drugs that post-licensure data show to be lethal (Vioxx, Gardasil, etc.). The FDA can't ensure a clean food supply (serrano peppers, salmonella in peanut butter, etc.). The FOOD and DRUG Administration is very bad at monitoring food and drugs... so its new head, Margaret Hamburg, thinks that a good idea would be for the FDA to become a public health organization whose aim is preventing disease. Say what? Is the FDA officially working for Big Pharma now, and will the CDC continue to work for Big Pharma, too? Will anyone bother to monitor peanut processing facilities for salmonella? Animal, Vegetable, Miracle is starting to look better and better to me...
FDA Chief Signals Public-Health Focus
By ALICIA MUNDYWASHINGTON -- In her first day on the job, Food and Drug Administration Commissioner Margaret "Peggy" Hamburg signaled that she sees the FDA as a public-health agency, and not just an organization that helps the food and drug industry market products. The agency's success should be measured by its impact on promoting health, preventing illness and prolonging life, not the number of facilities inspected or drugs approved, she wrote in a New England Journal of Medicine editorial published Tuesday. The article, co-authored by Deputy FDA Commissioner Joshua Sharfstein, also took the food industry and the agency to task over the salmonella outbreak linked to contaminated peanut products, saying it "represented more than a sanitation problem at one troubled facility." The two FDA officials blamed the agency's inability to enforce preventive controls and food manufacturers' inadequate monitoring of products from the peanut processor. Their article emphasized the FDA's role as regulator and highlighted the 2007 laws that strengthened the agency's ability to restrict use of medication at the time of approval, and to demand post-marketing studies. Drug and device makers have drawn criticism from Congress, consumer groups and doctors for stalling costly post-market studies. The editorial held out the prospect of quicker approvals for medicines whose makers show they are undertaking rigorous, scientifically valid studies of drugs and devices already on the market. Neither Dr. Hamburg nor Dr. Sharfstein was available for comment. Dr. Sharfstein, who has been acting commissioner since March 30, said last week he was eager for Dr. Hamburg to take over. He has dealt with voluntary recalls of pistachio products and a widely sold antipsoriasis drug; problems with an independent review board that had been overseeing patient safety in hundreds of clinical trials; and the outbreak of swine flu. He said his young son asked him during the last crisis, "Daddy, when the flu is over, then will you come home?" One of Dr. Sharfstein's first acts was to accelerate the FDA's reversal of a ban on the manufacture of liquid morphine. The prohibition, planned before Dr. Sharfstein joined the agency, was announced in early April and quickly undone after hospice workers and caregivers contacted the FDA to say their dying patients would suffer terrible pain without that medicine. Gail Austin Cooney, president of the American Academy of Hospice and Palliative Medicine said Dr. Sharfstein called her at home the evening of the reversal, to assure her that the liquid morphine would remain available. "He apologized for not taking the palliative patient population into consideration beforehand," she said, adding, "I'm amazed at how fast they fixed this." Dr. Cooney said that many patients in their final months of life only need to take a tiny amount of liquid morphine to manage their pain. Dr. Sharfstein also met for two hours with a group of whistleblowers from the medical-device division, who had written the Obama administration in January, urging that their division chiefs be replaced. Some attendees said that Dr. Sharfstein assured them their concerns would be addressed. Some in the industry are wary of the sudden shifts at the agency. Two pharmaceutical lobbyists said they are concerned that Dr. Sharfstein's recent review of the approval of a knee-surgery device through the division's fast-track process suggests that process might be slowed down. A lawyer whose clients include grocery outlets argued that the agency overreacted in the case of pistachios and a more recent warning on sprouts, which he worries indicates a more pre-emptive approach to food safety. Write to Alicia Mundy at alicia.mundy@wsj.com FDA Joined by FCC in the "On the Take" ClubBroadband over powerline... Sounds exciting, right? Getting high-speed internet over the same line that brings you your electricity... You may wonder if it's dangerous, but don't worry--the FCC has taken industry's word that it's safe. Hmmm... didn't some guys from the American Radio Relay League find out that they were wrong, and that the FCC is so full of bureaucrats (and so light on actual scientists) that no one there even noticed the snow job? I think I'll pass on BPL for now.
Did the FCC cook the books on broadband over power lines?Nonredacted documents related to the FCC's Broadband Over Power Line decision indicate that the agency did some pretty creative editing to come to its conclusions. By Matthew Lasar | Last updated May 14, 2009 8:45 AM CT
The other shoe has finally dropped on that court decision which forced the Federal Communications Commission to delay its green light to Broadband over Power Line technology (BPL). The American Radio Relay League (ARRL), which successfully sued the FCC over its go-ahead, has obtained and published a small pile of nonredacted versions of studies that the Commission claimed supported its pro-BPL position. The nonredacted documents, ARRL charges, offer a different assessment of the technology. For example, a redacted page (page one) from an FCC study of one BPL system's emissions rate (Main.net) concludes that it exceeded required limits, but "if distance were based on distance to the wire rather than the nearest part of the BPL system, measurements would have passed with 1 dB margin at the selected quasi-peak measurement location." What a relief! There's only one little problem. The unredacted version of the document (page two), now made public thanks to an ARRL Freedom of Information Act request, includes a parenthesis that was whited out of the comment. So the full sentence reads (we've added the emphasis): "if distance were based on distance to the wire rather than the nearest part of the BPL system (a suggestion made by Main.Net's CTO, but which we consider to be invalid), measurements would have passed with 1 dB margin at the selected quasi-peak measurement location." No adversity pleaseIt gets even weirder, but first let's review the background on this case. BPL, essentially a means of transmitting broadband along electrical current lines, was supposed to be the next big thing—a "third pipe" alternative to cable and DSL. But the market for it has been slow, and ham radio operators, led by the ARRL, charged that the service caused receiver interference.Finally a federal court took a look at the dispute and in April of 2008 agreed that the five studies used by the FCC to back its non-interference claims were full of redaction, so to speak. The Administrative Procedures Act requires the agency to make the whole of these studies public, the US Court of Appeals for the District of Columbia ruled, not just selected portions. Here, one judge declared, "there is little doubt that the Commission deliberately attempted to 'exclude[] from the record evidence adverse to its position'." This month ARRL got its hands on the clean studies. Here's another example. Page one of this document measuring the field strength of a BPL system component concludes that its "Plotted field strength is 95th percentile spectral bin within emission band of specified DUT for average." But do you see that great big blank box on the lower left of the page? That's a redacted comment. Scroll down to page two and you'll see the unredacted version of the page, which reveals the whited out text: ***NOT A POINT SOURCE*** Emissions exhibit no noticeable decay 230 m down line from couplerWhy would someone white this data out of a study? "FCC Part 15 emission limits were developed for point sources, i.e. for emissions from a single point," ARRL Chief Executive Officer David Sumner told Ars. "A BPL system uses wires, which of course are lines and not points and which radiate from along the line. What the FCC staff studies showed was that BPL is not a point source, and so the interference from a BPL device does not decay in the same way as a point source. It decays more slowly." Ditto for this page, which the agency completely blanked, except for the Powerpoint slide title: "Conclusions Regarding Access BPL." The unredacted version on page two says: "The tested overhead PLC devices do not act as point sources. Emission from line shows virtually no decay 230 m from coupler. Differential two-wire signal injection affects the polarization of radiated emissions from overhead devices." On the ARRL's comparison page, Sumner says his organization has only begun to explore these papers. "We are continuing to analyze all the documents and we'll see just what has been going on," he promised. The appeals court's procedural ruling remanded the controversy back to the FCC, which suggests that the agency could reissue its 2004 Order once it makes the relevant documents fully public. But it's unclear what the court or the FCC will do if it becomes obvious that the unredacted studies offer a meaningfully different assessment of the interference problem. Even the ARRL is circumspect in its analysis, however, cautiously suggesting that the unredacted docs "may not support [the FCC's] own conclusions regarding BPL." How "adverse" does the evidence have to be to compel the agency to change course? Hat tip to Broadband Reports for this story. 26 mai Rice Milk May Contain Dangerous Levels of Arsenic Try hemp milk, like Hemp Bliss, instead... http://www.dailymail.co.uk/news/article-1186722/Rice-milk-arsenic-contamination-prompts-food-watchdog-warning-children-stop-drinking-it.html?ITO=1490 Rice milk arsenic contamination prompts food watchdog warning for children
to stop drinking it
By Sean Poulter Toddlers and young children should not be given rice milk because it exposes them to arsenic, parents have been told. The Food Standards Agency issued the warning after an official study of 60 rice milk products showed all contained traces of the poison. Such contamination is a known problem associated with past pesticide use on the fields in which the rice crop is grown. Levels found in the study were below the current legal limit, and deemed safe for adults. But children and toddlers are at greater risk because they drink more milk relative to their size. Arsenic is known as a poison but is also associated with the development of certain cancers. The current legal limit is being reviewed by the European Food Safety Authority. The FSA said: 'As a precaution, toddlers and young children between one and 4.5 years old should not have rice drinks as a replacement for cows' milk, breast milk, or infant formula.' But it stressed: 'There is no immediate risk to children who have been consuming rice drinks and it is unlikely there would have been any long-term harmful effects, but to reduce further exposure to arsenic parents should stop giving these drinks to toddlers and young children.' In 2007 Aberdeen University researchers flagged up problems of arsenic contamination in both rice and rice milk. They found that one in five samples of American long-grain rice in British shops contained potentially harmful levels of arsenic. Research leader Professor Andrew Meharg said the FSA now needs to look at arsenic contamination of other types of rice, particularly baby rice. Good for What Ails You http://www.washingtonpost.com/wp-dyn/content/article/2009/05/22/AR2009052202280.html Doctor Uses Some Foods As MedicineBy Daphne Miller
Special to The Washington Post
Tuesday, May 26, 2009
"Just a cold? I thought I was dying." Martha sounded irritated. She had hustled the kids off to day care and skipped work, clearly expecting to hear that something more dramatic was brewing than a late springtime cold. But what motivated her visit to my office, I realized, was not the infection itself as much as the dizzying array of symptoms caused by her self-administered treatments: The fatigue and stomach pain appeared to intensify with each dose of opioid-derived cough suppressant she chugged; as for her headache, dry mouth and racing heart, they coincided suspiciously with a decongestant that contained pseudoephedrine (a close cousin to methamphetamine). Bolstered by a growing body of data and my own clinical experience, I opened my electronic medical record and entered a prescription that would give Martha relief without more side effects: mushroom ginger soup. The recipe sits right there on my screen, one click below morphine and one above mycostatin. There was a time when I might have scoffed at a physician whose pharmacopeia included gastronomical offerings. Like many of my colleagues, I left medical school with a sturdy respect for biomedical research and a belief that there was a drug to match every ill, or almost. When medication wasn't the answer, surely there was a surgery. Such illusions were swiftly dispelled within months of entering a family medical practice where my patients range in age from 2 minutes to 102 years and, on any given day, I am challenged with everything from upper-respiratory infections to asthma and lung cancer. Rare are the moments when a specific pill promises a quick fix. To the contrary, medications often produce a buckshot-like effect, hitting organs far beyond their intended target. So prescriptions to control cough end up causing incontinence, arrhythmias and sleepiness, and those for joint and low-back pain frequently kick off a series of digestive woes. Over the years, these frustrating experiences have prompted me to
take a closer look at nutrition and herbal research. Take that soup:
Unlike standard pharmaceutical cold preparations, which study after
study has shown do little to block symptoms or speed up recovery,
ginger and mushrooms have the potential to help, and with virtually no
ill effects. Indeed, a phalanx of lab-coated scientists have finally
convinced me of something that generations of traditional Chinese and
Japanese healers, and my great-grandmother, already knew to be true:
Ginger is an excellent decongestant, and mushrooms boost your immune
system. Some of the most compelling mushroom research has been done by Keith Martin, a nutritionist at Arizona State University and author of more than 30 papers in peer-reviewed journals. Martin and his colleagues have tested a variety of common mushrooms, such as white buttons and shiitakes, and found that in the presence of viruses such as those that cause cold and flu symptoms, all of them can raise the levels of the immune system's proteins to three to five times normal. Although mushroom extracts and supplements have gained popularity on store shelves, with promises that they can stop the spread of cancer and help manage infections, Martin cautions that no one has been able to definitively pinpoint the substances that give fungi the immune-boosting qualities he has identified. "Nutrition researchers have gotten themselves in trouble before when they tried to find the magic bullet in foods," he says, referring to studies where high-dose nutrient extracts given to reduce a cancer paradoxically caused a cancer spike in the study participants. Martin, who does get some funding from the mushroom industry, went on to advise that eating whole fungi rather than taking supplements is likely to be the healthier choice. Lucky for us, it happens to be the tastier option as well. Another favorite recipe in my EMR is turmeric stir fry. In 1999, while Merck and Pfizer were ceremoniously launching their painkillers Celebrex and Vioxx, researchers in the United Kingdom reported the results of laboratory research suggesting that curcumin extracts of turmeric (first referenced in ancient Sanskrit medical theses for its ability to soothe joints, wounds and intestinal tracts) could have the very same impact in treating arthritis pain. We all know how this story ends: Vioxx and Celebrex have since been linked to heart problems and stomach ulcers, while turmeric marches on, posing few risks other than its tendency to permanently stain your collar (and semi-permanently, your teeth). Not wanting to miss out on the action, nutraceutical companies have produced an array of anti-inflammatory, curcumin-containing supplements. Being mindful of wallets and taste buds (and aware that unregulated supplements sometimes don't contain what they purport to), I steer patients instead toward my turmeric stir fry and other turmeric-laced dishes. (They are also in my EMR below "Triphasal Birth Control Pills" and above "Tylenol"!) According to physician Tieraona Low Dog, chair of U.S. Pharmacopeia's Dietary Supplements and Botanicals Expert Committee: "You need to take two to three teaspoons per day of turmeric to see a benefit. Remember, though: Eat the turmeric with some fat and add black pepper, as this dramatically increases the absorption of the curcumin." Certainly recipes are not a panacea for our health woes; nor will EMRs clear up the quagmire that is our current medical system. But when it comes to treating the chronic or subacute medical problems that are the bread and butter of most primary care practices, non-pharmacological prescriptions for edibles (and, for that matter, exercise and mindful breathing) may have the potential to save billions of dollars annually, in both direct drug costs and the treatment of side effects. Most important, recipes offer an attractive alternative for those who are wary of popping too many pills. A recent study reported that 1.6 million Medicare beneficiaries per year fail to fill or refill one or more prescriptions. While some of the abandoned prescriptions may have been lifesaving or life-prolonging, somewhere between 35 and 65 percent were given to addresshealth issues such as osteoarthritis pain or the cough and congestion experienced by my patient Martha, all problems where pharmaceuticals have no clear advantage over other forms of treatment. In this study, the reasons Medicare beneficiaries gave for their "non-adherence" not doing what the doctor tells you to do) were varied: Some were worried about cost, some felt the medication would not work and others feared side effects. A tasty dish made with inexpensive ingredients from the local market could sidestep many of their concerns. After all, food is the one medicine that we seem quite willing to swallow -- at least three times a day. Daphne Miller is the author of "The Jungle Effect: A Doctor Discovers the Healthiest Diets From Around the World -- Why They Work and How to Bring Them Home." Comments: health@washpost.com. LASIK Not Always a Good Idea Years ago, I spent the weekend at the lake house of a friend of mine from college. His dad is an ophthalmologist, and he said that he would not do LASIK procedures because he felt they were too risky. Machines are calibrated for a particular distance above sea level, a particular humidity, etc., and if you're not operating under those conditions, then things can go wrong. He felt, he told us, that it was unethical to operate on a healthy eye. If a person with extremely poor vision was medically unable to wear glasses or contact lenses, he thought an exception might be made, but otherwise, the risk was not worth the benefit. I guess other people now agree: http://news.yahoo.com/s/nm/20090522/hl_nm/us_lasik_fda LASIK ads must warn consumers of risks: FDA
By Susan Heavey Susan Heavey
–
Fri May 22, 2:26 pm ET
WASHINGTON (Reuters) – Doctors, clinics and others promoting corrective eye surgery known as LASIK need to make sure their advertisements tell consumers about possible risks, U.S. regulators said in a letter released on Friday. The Food and Drug Administration, which has been investigating patient complaints over the procedure, told healthcare providers that commercials and other promotions that do not convey necessary warnings, side-effects and other precautions are deceptive. "Advertising and promotional materials for FDA-approved lasers used during LASIK procedures must be truthful, properly substantiated and not misleading," wrote Timothy Ulatowski, head of the Office of Compliance for the FDA's Center for Devices and Radiological Health. The letter comes more than a year after the FDA held a public meeting that drew dozens of unhappy patients who complained of blurriness, double-vision, depression and other problems after undergoing LASIK, or laser-assisted in-situ keratomileusis. Surgeons and other industry groups said the procedure is safe and effective when done properly and that most patients are satisfied with their vision afterward. LASIK involves cutting a flap in the eye and then using a laser to reshape the cornea, aiming to improve patients' vision so they can avoid glasses or contact lenses. About 700,000 Americans have undergone the procedure since it was approved in 1998, industry estimates have shown. The FDA's letter spares LASIK-related companies which could have been hurt by stricter action, including device makers Abbott Laboratories' unit Abbott Medical Optics Inc, Alcon Inc, and Bausch & Lomb as well as clinics such as TLC Vision Corp and LCA Vision Inc. A weak U.S. economy has already dampened demand for the elective surgery, which can cost several thousand dollars per eye and is not covered by most health insurers. The FDA splits oversight of LASIK advertising with the Federal Trade Commission, which could not be immediately reached for comment. If the FDA deems LASIK advertising misleading, it can issue warning letters as well as take stronger action such as imposing fines or making referrals for criminal investigation. But Diana Zuckerman, president of National Research Center for Women & Families, said the FDA could have done more than send a "vague" letter that does not help "patients in any meaningful way. "The problem is there are certain people who are unlikely to benefit (from LASIK) and they don't know who they are," she said. "At this point many people think LASIK is some kind of miracle ... and that's just not true." The agency should instead require doctors and clinics to give potential patients a simple, easy-to-understand booklet that lays out all the possible risks, Zuckerman said. FDA spokeswoman Mary Long said the agency has taken additional steps, including updating its website and making it easier for people to report problems to the FDA. The American Academy of Ophthalmology physicians' group said it appreciated the "reminder" from the FDA and would give the letter to its members. Other industry groups either could not be immediately reached or had no comment. (Reporting by Susan Heavey, editing by Dave Zimmerman) Don't Mix Ammonia and Chlorine No kidding. My mom told me this one years ago: don't mix Top Job and Clorox when you're cleaning out your desk on the last day of school. Ammonium chloride! It's toxic just to breathe it! I guess some people don't know that urine contains ammonia. Oops. Anyone who has walked through the tunnels at the Pacific Street-Atlantic Avenue subway station at 6 a.m. when the workers are hosing down the urine-stained walls with chlorine bleach knows that this is a bad combination... http://www.cnn.com/2009/HEALTH/05/22/pools.urinate.hygiene/ Tinkling in the pool causes disgust and discomfortupdated 9:11 a.m. EDT, Fri May 22, 2009 By Madison Park (CNN) -- As the summer swim season starts Memorial Day weekend, water quality and health experts have a message for swimmers: Please don't pee in the pool. Although urine in the water probably will not cause swimmers to go to the emergency room, it causes "more of a respiratory, ocular irritation: the red puffy eyes or a cough, an itchy throat," said Michele Hlavsa, an epidemiologist in the division of parasitic diseases at the Centers for Disease Control and Prevention."A big health message is not to urinate or pee in the water." And it happens far more frequently than water-lovers would like to think. In a survey of 1,000 U.S. adults conducted in April and May, 17 percent admitted relieving themselves in a swimming pool. Even the Olympics' most decorated swimmer, Michael Phelps, confessed to urinating in the water to TV host Jimmy Kimmel. In a 2008 interview, Kimmel asked the 14-gold medal winner, "You pee in the pool, true?" "Yeah," Phelps replied. "Which nationality pees in the pool the most?" Kimmel asked. "Probably Americans," Phelps said. "Oh, so we're number one in that too," Kimmel quipped. Sometimes, an indoor swimming pool will emit a strong chemical smell. The swimmers have coughs or red, stinging eyes after emerging from the pool. Usually those symptoms get dismissed as the effects of chlorine, but their causes are something more organic. When swimmers sweat or urinate in the pool water, the bodily fluids combine with the chlorine. It creates chloramines, which causes the strange odor and the eye and respiratory irritations for swimmers, according to the CDC. No matter how discreet the act may be, "you're contaminating the pool. Let's face it," said Linda Golodner, the vice chairwoman of the Water Quality and Health Council. The survey released by Golodner's group, which advises the American Chemistry Council, found that 11 percent of the surveyed adults said they have swum with a runny nose, 7 percent with an exposed rash or cut and 1 percent when ill with diarrhea. The margin of error was plus or minus 3.1 percentage points. The most common recreational water illness is spread through diarrhea. One of the most persistent problems is Cryptosporidium, a parasite that causes diarrhea and can be found in infected stools. "With Crypto, if you have diarrhea, it's very watery," Hlavsa said. "It's not a formed stool sitting in the pool or floating on top. It could be very watery, and no one [in a pool] would know." During the past two decades, Crypto has become one of the most common causes of waterborne illness. Unlike E. coli and salmonella, Crypto can resist chlorine. In 2007, the parasite sickened more than 1,200 people who had visited recreational water facilities in Utah. According to the CDC, if someone swallows water that has been contaminated with feces, he or she may become sick even if very little water is consumed. The agency also recommends that people shower before a swim, because most people have traces of feces on their bottoms, which can contaminate recreational water. In the Water Quality survey, 35 percent reported skipping a shower before swimming. Recreational water illnesses have been on the rise for the past two decades, according to the CDC. From 2005 to 2006, the agency reported 78 outbreaks of recreational water illnesses associated with swimming pools, water parks, hot tubs, lakes, rivers and oceans that affected 4,412 people and resulted in 116 hospitalizations and five deaths. Melanie Arthur, a mother of two in The Woodlands, Texas, maintains a swimming pool where her children play. "We are going to great lengths to train our 3-year-old to not go potty in the pool but to get out and go inside the house," Arthur said. "After maintaining our own pool, I hesitate to go to public pools. I am certain that they are not nearly as clean as my own." Just practice good hygiene when going for a swim, Hlavsa advised. "It's all about balancing risks," she said. "We think swimming is a great way to be physically active with family and friends." Check the CDC Web site for more on healthy swimming And remember, if you pee in the pool, you have to swim in it, too. Here are tips to make sure the pool is clean: • Look at the pool to see whether it's clean and clear, and the drain is visible. • Listen for pool equipment, because the pool pumps and filters should make noise. • Feel the tiles and pool sides. They should not be sticky or slippery. • Beware of a strong chemical odor. A well-chlorinated pool has little odor.Record Number of Vaccine Applications Now, ask yourself: Is there some disease out there of which I'm deathly afraid? Is there a vaccine I wish existed? No? Well, Big Pharma doesn't agree. Just wait a couple of years, and several new vaccines (of which you never dreamed, and which you never wanted) will be virtually mandatory for your child to attend school or daycare. http://therpmreport.com/Free/3b15afd4-a05a-4209-bc10-83d5b6c7fa2a.aspx?utm_source=RPMel Friday, May 22 2009 FDA Sees Boom in Vaccine ApplicationsBy Cole Werble Look for a big year for vaccine approvals in 2010. The agency expects a record number of new applications this year.
The
Food & Drug Administration expects to receive as many biological
license applications for new vaccine products in a four-month period
later this year as the agency has ever received in a full year. US Government Hands Cash to Big Pharma My mom said she read a newspaper article in which a guy from Sanofi was griping about how hard it's going to be for his company to make seasonal flu vaccines and swine flu vaccines. He implied that the company wouldn't make any extra money, because its capacity to produce vaccines can't expand quickly enough to make extra; it would just make swine flu instead of seasonal flu vaccines. Well, cry no longer, Sanofi, because the US taxpayers are going to pay for your troubles, to the tune of ONE BILLION DOLLARS. Yeah. Interesting to note that Novartis (Swiss), Sanofi (French), and GSK (British) are not American companies. Looks as if the bailout dollars are global! http://online.wsj.com/article/SB124303594956748749.html
For Flu Vaccine, U.S. Sets Aside $1 BillionBy BETSY MCKAYThe U.S. government is setting aside $1 billion to launch development of an H1N1 swine flu vaccine, as the disease continues to spread around the globe and its future course and severity remain unknown. The money, which comes from existing federal funding for pandemic flu and preparedness, will be used both for clinical studies this summer and for the production of two bulk ingredients that will be placed in a federal stockpile to be used if officials decide to go ahead with a large-scale vaccination program, the Department of Health and Human Services said Friday. The move marks a significant step toward making a vaccine that would protect people against the spreading new flu virus, but doesn't mean the government will definitely go ahead with mass production of shots. "The actions we are taking today will help us be prepared if a vaccine is needed," HHS Secretary Kathleen Sebelius said. The move also helps alleviate the risk manufacturers are taking on by producing ingredients for a vaccine that may or may not end up being used. HHS said it is placing orders for the ingredients with manufacturers with which it already has contracts to produce a pandemic vaccine -- contracts that were focused on the possibility of a pandemic of H5N1 avian flu. More than $3 billion in federal funds in the past four years have gone toward developing, building manufacturing and stockpiling a vaccine to fight that disease, which is much deadlier than the new H1N1 virus, but hasn't spread widely among humans. Novartis AG will receive $289 million, Sanofi Aventis SA will receive $191 million, and GlaxoSmithKline PLC will be given $181 million to produce H1N1 vaccine ingredients. HHS said it is also talking to additional manufacturers to find more capacity. Another $150 million will go to these manufacturers and others to produce pilot lots of vaccine and to pay for the clinical studies in which they will be used. The clinical studies will determine whether the vaccine is safe, the proper dose and whether adjuvants are needed -- an ingredient that improves the immune system response, reducing the amount of active ingredient needed for the vaccine. Scientists at the Centers for Disease Control and Prevention are analyzing two candidate viruses that could be used to make a vaccine, and plan to send one or both to manufacturers by the end of next week, so they can begin making pilot lots. The new H1N1 flu had reached 42 countries as of Friday, with 11,168 cases confirmed by laboratory tests, and 86 deaths, according to the World Health Organization. The U.S. had 6,552 confirmed and probable cases in 48 states and Washington, D.C., with nine deaths, according to the CDC. Under pressure from health officials around the world, the WHO said Friday it would alter its criteria for declaring a pandemic, to take into account not only the geographic spread of the disease, but also its severity. The WHO's pandemic alert currently stands at level 5, or one notch short of a pandemic, a sign to countries from the United Nations public-health agency that a pandemic is imminent. But the disease has been relatively mild thus far. WHO's chief, Margaret Chan, warned again Friday that the disease could easily become more lethal as it spreads, calling it a "subtle, sneaky virus" as she closed a weeklong meeting of global health officials. Keiji Fukuda, the WHO's flu chief, said the agency would take its lethality into account in evaluating whether to move the pandemic alert up to its highest notch. "What we will be looking for is events which signify a really substantial increase in risk of harm to people," he said. Write to Betsy McKay at betsy.mckay@wsj.com 22 mai Sharfstein Asks for More Industry Bribes to FDADid I say "bribes"? I meant fees! Higher fees from industry! Yeah, that won't influence the FDA's decision-making process at all, getting more money from industry...
Acting US FDA chief defends rise in industry feesThu May 21, 2009 4:15pm EDT
By Lisa Richwine WASHINGTON, May 21 (Reuters) - The acting head of the U.S. Food and Drug Administration defended the agency's request for more funding, including an increase in fees from industries the agency regulates. Democrats debating the FDA's budget voiced concern annual increases in industry fees might compromise the agency's work. "I understand the concern that people ... have expressed that user fees create a perception or a conflict of the agency's work," Acting FDA Commissioner Joshua Sharfstein told a U.S. House of Representatives appropriations subcommittee. "I think these concerns reflect a broader lack of trust in the FDA." To alleviate unease, the new FDA leadership under President Barack Obama must "renew the public's confidence by acting with integrity and transparency" and send "the signal inside and outside the agency that we will make decisions based on the best available scientific evidence and not on influence that's inappropriate." For fiscal 2010, Obama has asked the Democratic-controlled Congress for an FDA budget of $3.2 billion, including $828 million in fees from manufacturers of medical and food products. The fees include hundreds of millions of dollars drugmakers pay annually to help speed the review of new medicines. Obama's budget plan also seeks new fees to help clear a backlog of generic drug applications and to reinspect food and medical product plants that fail to meet FDA standards. Democratic Representative Maurice Hinchey said the growing percentage of fees from drugmakers "is something of great concern for a number of people on this committee." Sharfstein, speaking to reporters, said he did not think the industry fees had risen too high. Republicans, meanwhile, said it may be difficult to win authority from Congress to collect the new types of fees. "Every administration rolls out user fees and yet rarely do user fees get beyond this (subcommittee) hearing," said Republican Representative Jack Kingston. Sharfstein also said he wanted the FDA to be more proactive in encouraging development of new treatments. "We want to help get drugs to people who need them. At the same time we want to reduce the safety concerns. Both parts of the equation are important to us," he said at a separate hearing before a Senate Appropriations subcommittee. Stem cell research is one emerging field in which the FDA may be able to provide guidance on development before any products are submitted for approval, Sharfstein told reporters. Sharfstein, the FDA's principal deputy commissioner, is serving as the agency's acting chief until Dr. Margaret Hamburg steps into the top job. Hamburg was confirmed by the Senate on Monday. Sharfstein expected her to be sworn in as FDA commissioner next week. (Reporting by Lisa Richwine; Editing by Andre Grenon) 20 mai Jeffrey Smith on GMO DangersDoctors Warn: Avoid Genetically Modified Food
On May 19th, the American Academy of Environmental Medicine (AAEM) called on “Physicians to educate their patients, the medical community, and the public to avoid GM (genetically modified) foods when possible and provide educational materials concerning GM foods and health risks.”[1] They called for a moratorium on GM foods, long-term independent studies, and labeling. AAEM’s position paper stated, “Several animal studies indicate serious health risks associated with GM food,” including infertility, immune problems, accelerated aging, insulin regulation, and changes in major organs and the gastrointestinal system. They conclude, “There is more than a casual association between GM foods and adverse health effects. There is causation,” as defined by recognized scientific criteria. “The strength of association and consistency between GM foods and disease is confirmed in several animal studies.”
More and more doctors are already prescribing GM-free diets. Dr. Amy Dean, a Michigan internal medicine specialist, and board member of AAEM says, “I strongly recommend patients eat strictly non-genetically modified foods.” Ohio allergist Dr. John Boyles says “I used to test for soy allergies all the time, but now that soy is genetically engineered, it is so dangerous that I tell people never to eat it.”
Dr. Jennifer Armstrong, President of AAEM, says, “Physicians are probably seeing the effects in their patients, but need to know how to ask the right questions.” World renowned biologist Pushpa M. Bhargava goes one step further. After reviewing more than 600 scientific journals, he concludes that genetically modified organisms (GMOs) are a major contributor to the sharply deteriorating health of Americans.
Pregnant women and babies at great risk
Among the population, biologist David Schubert of the Salk Institute warns that “children are the most likely to be adversely effected by toxins and other dietary problems” related to GM foods. He says without adequate studies, the children become “the experimental animals.”[2]
The experience of actual GM-fed experimental animals is scary. When GM soy was fed to female rats, most of their babies died within three weeks—compared to a 10% death rate among the control group fed natural soy.[3] The GM-fed babies were also smaller, and later had problems getting pregnant.[4]
When male rats were fed GM soy, their testicles actually changed color—from the normal pink to dark blue.[5] Mice fed GM soy had altered young sperm.[6] Even the embryos of GM fed parent mice had significant changes in their DNA.[7] Mice fed GM corn in an Austrian government study had fewer babies, which were also smaller than normal.[8]
Reproductive problems also plague livestock. Investigations in the state of Haryana, India revealed that most buffalo that ate GM cottonseed had complications such as premature deliveries, abortions, infertility, and prolapsed uteruses. Many calves died. In the US, about two dozen farmers reported thousands of pigs became sterile after consuming certain GM corn varieties. Some had false pregnancies; others gave birth to bags of water. Cows and bulls also became infertile when fed the same corn.[9]
In the US population, the incidence of low birth weight babies, infertility, and infant mortality are all escalating.
Food designed to produce toxin
GM corn and cotton are engineered to produce their own built-in pesticide in every cell. When bugs bite the plant, the poison splits open their stomach and kills them. Biotech companies claim that the pesticide, called Bt—produced from soil bacteria Bacillus thuringiensis—has a history of safe use, since organic farmers and others use Bt bacteria spray for natural insect control. Genetic engineers insert Bt genes into corn and cotton, so the plants do the killing. The Bt-toxin produced in GM plants, however, is thousands of times more concentrated than natural Bt spray, is designed to be more toxic,[10] has properties of an allergen, and unlike the spray, cannot be washed off the plant. Moreover, studies confirm that even the less toxic natural bacterial spray is harmful. When dispersed by plane to kill gypsy moths in the Pacific Northwest, about 500 people reported allergy or flu-like symptoms. Some had to go to the emergency room.[11],[12] The exact same symptoms are now being reported by farm workers throughout India, from handling Bt cotton.[13] In 2008, based on medical records, the Sunday India reported, “Victims of itching have increased massively this year . . . related to BT cotton farming.”[14]
GMOs provoke immune reactions
AAEM states, “Multiple animal studies show significant immune dysregulation,” including increase in cytokines, which are “associated with asthma, allergy, and inflammation”—all on the rise in the US.
According to GM food safety expert Dr. Arpad Pusztai, changes in the immune status of GM animals are “a consistent feature of all the studies.”[15] Even Monsanto’s own research showed significant immune system changes in rats fed Bt corn.[16] A November 2008 by the Italian government also found that mice have an immune reaction to Bt corn.[17] GM soy and corn each contain two new proteins with allergenic properties,[18] GM soy has up to seven times more trypsin inhibitor—a known soy allergen,[19] and skin prick tests show some people react to GM, but not to non-GM soy.[20] Soon after GM soy was introduced to the UK, soy allergies skyrocketed by 50%. Perhaps the US epidemic of food allergies and asthma is a casualty of genetic manipulation.
Animals dying in large numbers
In India, animals graze on cotton plants after harvest. But when shepherds let sheep graze on Bt cotton plants, thousands died. Post mortems showed severe irritation and black patches in both intestines and liver (as well as enlarged bile ducts). Investigators said preliminary evidence “strongly suggests that the sheep mortality was due to a toxin. . . . most probably Bt-toxin.”[21] In a small follow-up feeding study by the Deccan Development Society, all sheep fed Bt cotton plants died within 30 days; those that grazed on natural cotton plants remained healthy.
In a small village in Andhra Pradesh, buffalo grazed on cotton plants for eight years without incident. On January 3rd, 2008, the buffalo grazed on Bt cotton plants for the first time. All 13 were sick the next day; all died within 3 days.[22]
Bt corn was also implicated in the deaths of cows in Germany, and horses, water buffaloes, and chickens in The Philippines.[23]
In lab studies, twice the number of chickens fed Liberty Link corn died; 7 of 20 rats fed a GM tomato developed bleeding stomachs; another 7 of 40 died within two weeks.[24] Monsanto’s own study showed evidence of poisoning in major organs of rats fed Bt corn, according to top French toxicologist G. E. Seralini.[25]
Worst finding of all—GMOs remain inside of us
The only published human feeding study revealed what may be the most dangerous problem from GM foods. The gene inserted into GM soy transfers into the DNA of bacteria living inside our intestines and continues to function.[26] This means that long after we stop eating GMOs, we may still have potentially harmful GM proteins produced continuously inside of us. Put more plainly, eating a corn chip produced from Bt corn might transform our intestinal bacteria into living pesticide factories, possibly for the rest of our lives.
When evidence of gene transfer is reported at medical conferences around the US, doctors often respond by citing the huge increase of gastrointestinal problems among their patients over the last decade. GM foods might be colonizing the gut flora of North Americans.
Warnings by government scientists ignored and denied
Scientists at the Food and Drug Administration (FDA) had warned about all these problems even in the early 1990s. According to documents released from a lawsuit, the scientific consensus at the agency was that GM foods were inherently dangerous, and might create hard-to-detect allergies, poisons, gene transfer to gut bacteria, new diseases, and nutritional problems. They urged their superiors to require rigorous long-term tests.[27] But the White House had ordered the agency to promote biotechnology and the FDA responded by recruiting Michael Taylor, Monsanto’s former attorney, to head up the formation of GMO policy. That policy, which is in effect today, denies knowledge of scientists’ concerns and declares that no safety studies on GMOs are required. It is up to Monsanto and the other biotech companies to determine if their foods are safe. Mr. Taylor later became Monsanto’s vice president.
Dangerously few studies, untraceable diseases
AAEM states, “GM foods have not been properly tested” and “pose a serious health risk.” Not a single human clinical trial on GMOs has been published. A 2007 review of published scientific literature on the “potential toxic effects/health risks of GM plants” revealed “that experimental data are very scarce.” The author concludes his review by asking, “Where is the scientific evidence showing that GM plants/food are toxicologically safe, as assumed by the biotechnology companies?”[28]
Famed Canadian geneticist David Suzuki answers, “The experiments simply haven’t been done and we now have become the guinea pigs.” He adds, “Anyone that says, ‘Oh, we know that this is perfectly safe,’ I say is either unbelievably stupid or deliberately lying.”[29]
Dr. Schubert points out, “If there are problems, we will probably never know because the cause will not be traceable and many diseases take a very long time to develop.” If GMOs happen to cause immediate and acute symptoms with a unique signature, perhaps then we might have a chance to trace the cause.
This is precisely what happened during a US epidemic in the late 1980s. The disease was fast acting, deadly, and caused a unique measurable change in the blood—but it still took more than four years to identify that an epidemic was even occurring. By then it had killed about 100 Americans and caused 5,000-10,000 people to fall sick or become permanently disabled. It was caused by a genetically engineered brand of a food supplement called L-tryptophan.
If other GM foods are contributing to the rise of autism, obesity, diabetes, asthma, cancer, heart disease, allergies, reproductive problems, or any other common health problem now plaguing Americans, we may never know. In fact, since animals fed GMOs had such a wide variety of problems, susceptible people may react to GM food with multiple symptoms. It is therefore telling that in the first nine years after the large scale introduction of GM crops in 1996, the incidence of people with three or more chronic diseases nearly doubled, from 7% to 13%.[30]
To help identify if GMOs are causing harm, the AAEM asks their “members, the medical community, and the independent scientific community to gather case studies potentially related to GM food consumption and health effects, begin epidemiological research to investigate the role of GM foods on human health, and conduct safe methods of determining the effect of GM foods on human health.”
Citizens need not wait for the results before taking the doctors advice to avoid GM foods. People can stay away from anything with soy or corn derivatives, cottonseed and canola oil, and sugar from GM sugar beets—unless it says organic or “non-GMO.” There is a pocket Non-GMO Shopping Guide, co-produced by the Institute for Responsible Technology and the Center for Food Safety, which is available as a download, as well as in natural food stores and in many doctors’ offices.
If even a small percentage of people choose non-GMO brands, the food industry will likely respond as they did in Europe—by removing all GM ingredients. Thus, AAEM’s non-GMO prescription may be a watershed for the US food supply.
International bestselling author and independent filmmaker Jeffrey M. Smith is the Executive Director of the Institute for Responsible Technology and the leading spokesperson on the health dangers of GMOs. His first book, Seeds of Deception is the world’s bestselling book on the subject. His second, Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods, identifies 65 risks of GMOs and demonstrates how superficial government approvals are not competent to find most of them. He invited the biotech industry to respond in writing with evidence to counter each risk, but correctly predicted that they would refuse, since they don’t have the data to show that their products are safe.
[1] http://www.aaemonline.org/gmopost.html [2] David Schubert, personal communication to H. Penfound, Greenpeace Canada, October 25, 2002. [3] Irina Ermakova, “Genetically modified soy leads to the decrease of weight and high mortality of rat pups of the first generation. Preliminary studies,” Ecosinform 1 (2006): 4–9. [4] Irina Ermakova, “Experimental Evidence of GMO Hazards,” Presentation at Scientists for a GM Free Europe, EU Parliament, Brussels, June 12, 2007 [5] Irina Ermakova, “Experimental Evidence of GMO Hazards,” Presentation at Scientists for a GM Free Europe, EU Parliament, Brussels, June 12, 2007[6] L. Vecchio et al, “Ultrastructural Analysis of Testes from Mice Fed on Genetically Modified Soybean,” European Journal of Histochemistry 48, no. 4 (Oct–Dec 2004):449–454. [7] Oliveri et al., “Temporary Depression of Transcription in Mouse Pre-implantion Embryos from Mice Fed on Genetically Modified Soybean,” 48th Symposium of the Society for Histochemistry, Lake Maggiore (Italy), September 7–10, 2006. [8] Alberta Velimirov and Claudia Binter, “Biological effects of transgenic maize NK603xMON810 fed in long term reproduction studies in mice,” Forschungsberichte der Sektion IV, Band 3/2008 [9] Jerry Rosman, personal communication, 2006 [10] See for example, A. Dutton, H. Klein, J. Romeis, and F. Bigler, “Uptake of Bt-toxin by herbivores feeding on transgenic maize and consequences for the predator Chrysoperia carnea,” Ecological Entomology 27 (2002): 441–7; and J. Romeis, A. Dutton, and F. Bigler, “Bacillus thuringiensis toxin (Cry1Ab) has no direct effect on larvae of the green lacewing Chrysoperla carnea (Stephens) (Neuroptera: Chrysopidae),” Journal of Insect Physiology 50, no. 2–3 (2004): 175–183. [11] Washington State Department of Health, “Report of health surveillance activities: Asian gypsy moth control program,” (Olympia, WA: Washington State Dept. of Health, 1993). [12] M. Green, et al., “Public health implications of the microbial pesticide Bacillus thuringiensis: An epidemiological study, Oregon, 1985-86,” Amer. J. Public Health 80, no. 7(1990): 848–852. [13] Ashish Gupta et. al., “Impact of Bt Cotton on Farmers’ Health (in Barwani and Dhar District of Madhya Pradesh),” Investigation Report, Oct–Dec 2005. [14] Sunday India, October, 26, 2008 [15] October 24, 2005 correspondence between Arpad Pusztai and Brian John [16] John M. Burns, “13-Week Dietary Subchronic Comparison Study with MON 863 Corn in Rats Preceded by a 1-Week Baseline Food Consumption Determination with PMI Certified Rodent Diet #5002,” December 17, 2002 http://www. monsanto.com/monsanto/content/sci_tech/prod_safety/fullratstudy.pdf [17] Alberto Finamore, et al, “Intestinal and Peripheral Immune Response to MON810 Maize Ingestion in Weaning and Old Mice,” J. Agric. Food Chem., 2008, 56 (23), pp 11533–11539, November 14, 2008 [18] See L Zolla, et al, “Proteomics as a complementary tool for identifying unintended side effects occurring in transgenic maize seeds as a result of genetic modifications,” J Proteome Res. 2008 May;7(5):1850-61; Hye-Yung Yum, Soo-Young Lee, Kyung-Eun Lee, Myung-Hyun Sohn, Kyu-Earn Kim, “Genetically Modified and Wild Soybeans: An immunologic comparison,” Allergy and Asthma Proceedings 26, no. 3 (May–June 2005): 210-216(7); and Gendel, “The use of amino acid sequence alignments to assess potential allergenicity of proteins used in genetically modified foods,” Advances in Food and Nutrition Research 42 (1998), 45–62. [19] A. Pusztai and S. Bardocz, “GMO in animal nutrition: potential benefits and risks,” Chapter 17, Biology of Nutrition in Growing Animals, R. Mosenthin, J. Zentek and T. Zebrowska (Eds.) Elsevier, October 2005 [20] Hye-Yung Yum, Soo-Young Lee, Kyung-Eun Lee, Myung-Hyun Sohn, Kyu-Earn Kim, “Genetically Modified and Wild Soybeans: An immunologic comparison,” Allergy and Asthma Proceedings 26, no. 3 (May–June 2005): 210-216(7). [21] “Mortality in Sheep Flocks after Grazing on Bt Cotton Fields—Warangal District, Andhra Pradesh” Report of the Preliminary Assessment, April 2006, http://www.gmwatch.org/archive2.asp [22] Personal communication and visit, January 2009. [23] Jeffrey M. Smith, Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods, Yes! Books, Fairfield, IA USA 2007 [24] Arpad Pusztai, “Can Science Give Us the Tools for Recognizing Possible Health Risks for GM Food?” Nutrition and Health 16 (2002): 73–84. [25] Stéphane Foucart, “Controversy Surrounds a GMO,” Le Monde, 14 December 2004; referencing, John M. Burns, “13-Week Dietary Subchronic Comparison Study with MON 863 Corn in Rats Preceded by a 1-Week Baseline Food Consumption Determination with PMI Certified Rodent Diet #5002,” December 17, 2002 http://www.monsanto.com/monsanto/content/sci_tech/prod_safety/fullratstudy.pdf [26] Netherwood et al, “Assessing the survival of transgenic plant DNA in the human gastrointestinal tract,” Nature Biotechnology 22 (2004): 2. [27] See memos at www.biointegrity.org [28] José Domingo, “Toxicity Studies of Genetically Modified Plants : A Review of the Published Literature,” Critical reviews in food science and nutrition, 2007, vol. 47, no8, pp. 721-733 [29] Angela Hall, “Suzuki warns against hastily accepting GMOs”, The Leader-Post (Canada), 26 April 2005. [30] Kathryn Anne Paez, et al, “Rising Out-Of-Pocket Spending For Chronic Conditions: A Ten-Year Trend,” Health Affairs, 28, no. 1 (2009): 15-25 19 mai Dick Morris on HealthcareYeah, I hate him, but he's right.
DEATH OF U.S. HEALTHCARE
By DICK MORRIS
Published on TheHill.com on May 12, 2009
Printer-Friendly Version
When all of America’s top health insurers and providers met at the White House this week and pledged to save $2 trillion over the next decade in health costs, they were pledging to sabotage our medical care. The blunt truth, which everybody agreed to keep quiet, is that the only way to reduce these costs is to ration healthcare, thereby destroying our system. Here’s why:
• Essential to any cost reduction is a cut in doctors’ fees. Congress is trying to cut Medicare fees by 21 percent. But cuts in fees and doctors’ incomes will just discourage people from entering the profession and those already in it from practicing. The limited number of doctors and nurses in the United States is the key constraint on the availability of healthcare. Our national inventory of 800,000 doctors is growing at only about 1 percent a year (18,000 med school graduates annually minus retirements), while the nurse population is stagnant at 1.4 million. To stretch these limited resources so that they can treat 50 million more people is possible only through the most severe kind of rationing.
• As in Canada, the best way to cut medical costs is to refrain from using the best drugs to treat cancer and other illnesses, thereby economizing at the expense of patients’ lives. Forty-four percent of the drugs approved by the Canadian health authorities for use in their country are not allowed by the healthcare system due to their high cost. As a result, death rates from cancer are 16 percent higher in Canada than in the United States. We will pay for the attempt to save $2 trillion with our lives. (And remember, one cannot opt out of the Canadian system and pay for the medications out of pocket.)
• The only real way to save money on the scale projected is to ration healthcare services. Optimists say that this can be achieved by increased use of preventive care. But the Canadian experience indicates that when government — or its satellite private insurance providers — ration healthcare, they cut preventive care first. In Canada, colonoscopies are so rationed that the colon cancer rate is 25 percent higher than in the U.S. (even though Canada has a much smaller proportion of poor people, whose frequently bad diets make them more prone to the disease).
Obama’s pretension that nobody will find changes in his or her current health insurance plans except for a magical reduction in their cost by $2,500 a year is a fool’s proposition. Private health insurers will be no more private than TARP-funded banks or government-subsidized car companies are in Obama’s America. They will be controlled by government healthcare planners who will approve treatments, limit drug use, hold down medical incomes and bring their cost-cutting programs to bear. Inevitably, their ax will fall on the oldest and the sickest among us, those least “deserving” of our newly limited and, under Obama’s program, diminishing healthcare resources.
The other radical changes Obama is bringing about in our nation can always be reversed. New taxes can be repealed or lowered. That which was nationalized can be privatized. Government which has grown can be cut. But once the healthcare system is extended to cover everyone, with no commensurate increase in the resources available, the change will be forever. The vicious cycle of cuts in medical resources and in the number of doctors and nurses will doom healthcare in this country. This wanton destruction will not be reversible by any bill or program. A crucial part of our quality of life — the best healthcare in the world — will be gone forever.
Politically, voters will feel the impact of these “reforms” very quickly. When they face rejection or limitation at the hands of the bureaucrats, they will quickly understand that the their options have become limited. Just as in the 1990s, when HMOs first became universal, the patient outrage will create a political force all its own and those who foisted this brave new world on the American people will be in their crosshairs. How About Taxing Bread Made with High-Fructose Corn Syrup?Oh, wait, that would be NEARLY EVERY BRAND. This is the type of legislation I hate: linking two things that are not inherently related, like allowing gambling (lottery) and using the money to provide benefits to senior citizens, or denying federal highway funds to states that lower the drinking age to 18 (as the feds did to Louisiana several years ago). Drinking and driving is a terrible offense--I would support extremely high penalties for anyone caught drinking and driving, even in non-accident situations--but allowing 18-year-olds to drink does not mean that those same individuals will drink and drive. Revoking someone's license for drinking underage? Equally unfair. If the person wasn't in a car, why should the punishment involve a car?
Anyway, we have some more BS coming our way from the government, suggesting that we should tax soda in order to pay for health care. If we're really going to force Americans to "eat right," then everyone should be on the Michael Pollan diet. Taxing soda and not Wonder Bread is hypocrisy.
U.S. lawmakers weigh beverage taxes in health revampMon May 18, 2009 3:56pm EDT
By Donna Smith WASHINGTON (Reuters) - A tax on soft drinks and other sweetened beverages and higher taxes on alcohol are among the options U.S. lawmakers will consider to pay for expanded healthcare coverage, a Senate report said on Monday. The beverage taxes were among the options outlined in a Senate Finance Committee report that panel members will review in a closed-door session on Wednesday. Senators will look at a mix of taxes and cost savings to pay for a healthcare overhaul that aims to provide affordable medical coverage for all Americans, including an estimated 46 million who have no insurance. Wednesday's session will likely be contentious as lawmakers search for politically palatable ways to finance health reform amid soaring budget deficits. President Barack Obama wants Congress to pass the overhaul by the end of the year. He has called for a $634 billion "reserve fund" in his budget as a downpayment toward expanding coverage to the uninsured. Many analysts believe the final cost is likely to be much higher. Senate Finance Committee Chairman Max Baucus, and other Democrats, argue that an overhaul of the $2.5 trillion U.S. healthcare system is needed to control soaring costs. "Without healthcare reform, healthcare spending will reach $4.4 trillion by 2018," Baucus said in a statement accompanying the release of the possible financing options. The committee is expected to draft healthcare legislation next month with aim of winning Senate passage by August. The House of Representatives is working on a similar timetable. Raising taxes on sweetened beverages would provide an added benefit in helping to fight obesity, which drives up healthcare costs, the committee report said. The proposal calls for no tax on artificially sweetened drinks. Another option would raise taxes on all types of alcohol and apply a standard rate. Taxes now are lower for beer and wine, which are based on volume, than for distilled spirits, which are based on alcohol content. Other options include limiting some of the current federal tax subsidies for healthcare, which amounted to $194.2 billion in 2008. In particular, lawmakers are looking at limiting a tax break for employer-provided health insurance, a proposal opposed by labor unions. Lawmakers are also looking at cost savings in the Medicare and Medicaid health programs for the elderly and poor, including requiring high-income earners to pay more for their Medicare drug coverage. 18 mai FDA Under Thumb of Chemical IndustryAnother shocker.
FDA relied heavily on BPA lobbyRegulators actively reached out to industry, e-mails showBy Susanne Rust and Meg Kissinger of the Journal Sentinel Posted: May. 16, 2009 As federal regulators hold fast to their claim that a chemical in baby bottles is safe, e-mails obtained by the Journal Sentinel show that they relied on chemical industry lobbyists to examine bisphenol A's risks, track legislation to ban it and even monitor press coverage. In one instance, the U.S. Food and Drug Administration's deputy director sought information from the BPA industry's chief lobbyist to discredit a Japanese study that found it caused miscarriages in workers who were exposed to it. This was before government scientists even had a chance to review the study. "I'd like to get information together that our chemists could look at to determine if there are problems with that data in advance of possibly reviewing the study," Mitchell Cheeseman, deputy director of the FDA's center for food safety and applied nutrition, said in an e-mail seeking advice from Steven Hentges, executive director of the trade association's BPA group. The FDA relied on two studies - both paid for by chemical makers - to form the framework of its draft review declaring BPA to be safe. The Journal Sentinel reported last year that the trade group wrote entire sections of that draft. But the revelations contained in these e-mails show a pattern of preferential treatment over the past nine years that was not afforded to independent scientists. Hentges did not respond to requests for comment. However, Kathryn St John, spokeswoman for the American Chemistry Council, said, "We take very seriously our responsibility to fully communicate and cooperate with government regulatory authorities in a transparent manner, in compliance with legal and regulatory requirements." She said she could not comment on specifics. BPA, used to make hard, clear plastic common in many food product containers, is found in the urine of 93% of Americans. It has been linked to neurological defects, diabetes, breast and prostate cancer and heart disease. The Journal Sentinel contacted several independent scientists who are BPA experts, and all said they were not given such access to FDA safety assessors. Nor did the FDA seek their opinions or ask them to review studies, they said. On the contrary, some said they were discouraged at not being able to get their views across to government regulators, and resented what they saw as uneven treatment. Representatives for the Natural Resources Defense Council, an environmental activist organization that is working to ban BPA, said they have tried unsuccessfully for years to meet with FDA regulators. Sarah Janssen, a scientist with the NRDC, said the government agency has not responded to a petition it filed in October to ban BPA from food products. The e-mails show how government regulators relied on the trade association to do much of their work for them. In one e-mail, the FDA asked Hentges to give the trade association's opinion of a study by the U.S. Centers for Disease Control and Prevention on the prevalence of BPA. It is not clear why the FDA wouldn't do its own analysis or have the CDC provide that information. FDA administrators declined to comment on the specifics of the e-mails. But Jesse Goodman, newly appointed as the FDA's acting chief medical officer, said the agency will take a "fresh look" at BPA that will include a wider network of opinions than previously had been considered. "We have heard the criticism" about the FDA being too cozy with chemical makers, Goodman said. "We are following through to make sure that we look at all the science." In October, the FDA's own advisory committee said that its examination was not thorough enough and that FDA scientists improperly discounted dozens of studies that showed the chemical caused harm. The committee recommended that the FDA reopen its review of the chemical, but so far the agency has not changed its opinion. And, six months later, the FDA has yet to hold a public meeting on BPA safety. A spate of local and state bans on BPA has passed recently - including those in Chicago and Minnesota - and more are being considered. The bans prohibit the sale of products made with BPA for children under the age of 3. In March, Suffolk County on New York's Long Island banned BPA in children's products. Similar bans have been proposed in Michigan, Maine, Massachusetts, New York state and Connecticut. Bills have been introduced in the House and the Senate to ban BPA in all food packaging. Dozens of e-mails and more than 100 pages of attachments were obtained through the Freedom of Information Act. They show that chemical trade association lobbyists routinely have met with FDA administrators over the past nine years to give their opinion on various independent studies on the effects of BPA. At times, the lobbyists' comments appeared to dismiss work as incomplete or amateurish. In flagging the FDA to a study from the University of Cincinnati that showed that BPA leaches from bottles when it is heated, Hentges seemed to belittle the effort as "a summer project for a couple of undergraduates." Scott Belcher, who oversaw the research, defended the study. He bristled at the relationship between the government agency and the trade group. "Science aside, as a consumer it is pretty unsettling to hear that someone who is paid to represent a powerful special interest group would even have access to influence FDA officials by raising points like those," he said. The FDA has invited the trade association to come to its headquarters several times since 2000 to make presentations on BPA. At these meetings, lobbyists for the chemical makers provided the FDA with the current status of regulatory legislation in states, cities and other countries. And they provided the FDA with their assessments of current science. The lobbyists met with government regulators to brief them on the developments regarding BPA even as independent scientists' requests for discussions were being rebuffed. On July 24, 2007, for example, the lobbyists gave a 26-slide PowerPoint presentation to FDA regulators, updating them on developments concerning BPA. Among their objectives was to gain understanding of the views of the FDA. The lobbyists used the time with government regulators to give details of their agenda, to go over recent regulatory and legislative activities, and to discuss their research developments. The overview included advice from the lobbyists for how the government should consider news developments. "New science, government activities and non-governmental organizations are news triggers," the trade group wrote in its PowerPoint. In other e-mails, trade lobbyists notified FDA officials about upcoming news reports on BPA and advised them how to respond. "Laura and Mitch," Hentges wrote in an e-mail to FDA administrators. "I send this note to give you a head's up on something we understand is coming next week." The item was a report from the Environmental Working Group, an activist organization working to ban BPA. "At this time we have no information on what information they will report or how it will be publicized," Hentges wrote. "However, we can anticipate that it will be widely publicized as a serious food safety issue. If correct, it might be appropriate for FDA to consider issuing a statement to reassure consumers about the safety of the food supply." Other scientists, such as Fred vom Saal, a University of Missouri scientist who is working to ban the chemical, say they are outraged at not being afforded the same access. "This is appalling," vom Saal said. "These people are really now and have obviously been for a long time in industry's pocket." 14 mai RotaTeq Not Worth the Cost(That's not even including the death toll!) Click over to Age of Autism to read about this...
Is the RotaTeq Vaccine Cost Effective As We Rein In Healthcare Costs?Hug a Wounded Veteran Today... because odds are, he was misled about his recovery time by a shill for Medtronic. You suffer for your country, and then you come home to paid-off doctors and crappy care. God bless America.
Army Investigation Cites Problems in Surgeon's StudyBy TOM BURTONAn investigation by Walter Reed Army Medical Center in Washington found "a number of serious questions" about a study by a former surgeon at the hospital evaluating the use of a bone-growth protein in soldiers with leg fractures. Army documents show investigators concluded that the former Walter Reed surgeon, Timothy R. Kuklo, forged his purported co-authors' signatures on the study and that the number of injured soldiers differs from the Army's records of its wartime casualties. Hospital officials said the study was based on "falsified information." Dr. Kuklo's research, published in August and since retracted by the Journal of Bone and Joint Surgery, seemingly showed advantages in healing of leg injuries when doctors used the bone protein, called Infuse, from Medtronic Inc. Dr. Kuklo is a consultant for the Minneapolis company; Medtronic said he didn't have any company affiliation at the time he worked on the study. The company declined to disclose any other information about his consultancy. The New York Times reported the news earlier. Dr. Kuklo now is on staff in St. Louis at Washington University School of Medicine, which declined to comment. Dr. Kuklo didn't respond to calls and emails left at his office. Write to Tom Burton at tom.burton@wsj.com 13 mai What Do We Really Know About the So-Called Greenhouse Effect?Read here, then below.
Document Is Critical of E.P.A. on Clean Air
Published: May 12, 2009
WASHINGTON — An internal government memorandum that came to light on Tuesday challenged the scientific and economic basis of a proposed Environmental Protection Agency finding that climate-altering gases are a threat to human health and welfare. The undated and unsigned government document, marked “Deliberative — Attorney Client Privilege,” was compiled by the White House Office of Management and Budget from comments offered by various agencies. A White House official said that many of the criticisms and suggestions came from holdovers from the administration of President George W. Bush and had been rejected by Obama appointees. The nine-page document was part of a multiagency review of the proposed E.P.A. finding and had little impact on the final agency document, which was issued on April 17, officials said. But opponents of the Obama administration’s approach to the regulation of heat-trapping gases seized on the memorandum in a flurry of press statements and in a Senate hearing on Tuesday. The document said the proposed finding that greenhouse gases threatened health and the environment was not based on a systematic analysis of costs and benefits and fell short of scientific rigor on a number of issues. It also said that the E.P.A.’s proposal to regulate carbon dioxide under the Clean Air Act would have “serious economic consequences for regulated entities throughout the U.S. economy, including small businesses and small communities.” The document also questioned the agency’s inclusion of gases that are believed to contribute to global warming without proving that they had adverse health effects. Some of the objections mirror longstanding criticism of the proposed E.P.A. action from Republicans and business lobbies who say that the Clean Air Act is the wrong instrument for combating global warming and that such regulation will have devastating effects on the economy. Senator John Barrasso, Republican of Wyoming, waved the document at Lisa P. Jackson, the E.P.A. administrator, at a hearing of the Environment and Public Works Committee. Mr. Barrasso called it a “smoking gun” that proved that the proposed finding was based on politics, not science. “This misuse of the Clean Air Act will be a trigger for overwhelming regulation and lawsuits based on gases emitted from cars, schools, hospitals and small business,” Mr. Barrasso said. “This will affect any number of other sources, including lawn mowers, snowmobiles and farms. This will be a disaster for the small businesses that drive America.” Ms. Jackson replied that the E.P.A. was obligated by the Supreme Court to decide whether heat-trapping gases pose a danger to human health and the environment. She said much of the analysis behind the proposed finding had been completed before she assumed office in January. She added that the comments reflected “people’s opinions” and were not binding on the agency. Ms. Jackson also reiterated that the Obama administration wanted a legislative solution based on a cap-and-trade program for emissions of heat-trapping gases rather than a regulatory scheme dictated by the E.P.A. “We do understand there are costs to the economy of regulating greenhouse emissions,” she said. Peter R. Orszag, the president’s budget director, wrote on a White House blog that the comments in the document did not reflect his views or the president’s. Mr. Orszag said the proposed finding was “carefully rooted in both law and science” and did not, by itself, impose any regulations. “If and when the endangerment finding is made final,” he wrote, repeating comments he made when the preliminary finding was issued, “the E.P.A. will turn to the question whether and how to regulate greenhouse gas emissions from new automobiles.” |
|
|